RaQualia, CJ CheilJedang sign licensing deal
Under the contract, RaQualia has licensed the development, manufacturing and commercialization rights of 5-HT4 Partial Agonist (RQ-00000010) to CJ in India, Taiwan, Korea and South Asia. As per

Under the contract, RaQualia has licensed the development, manufacturing and commercialization rights of 5-HT4 Partial Agonist (RQ-00000010) to CJ in India, Taiwan, Korea and South Asia. As per

Prevnar 13 is indicated for active immunization for the prevention of pneumococcal disease in adult patients aged 50 and older. The FDA has extended the review period till

The SC formulation of Orencia is a fixed 125mg dose which can be given weekly through an injection under the skin following a single IV loading dose of

The partnership will allow Gates Foundation to use images and video of FC Barcelona team to support awareness efforts. The two parties will use their own financial resources

NAMN is a provider of medical nutritional products like: dietary products, enteral clinical nutrition, disease specific nutrition for children, sick and elderly people. NAMN offers products under brands

MOgene said its new sanger-like reads delivers millions of bases from Sanger-length reads. MOgene VP Shaukat Rangwala said the greatest benefit of this long read technology is in

Lannett’s Phentermine Resin Extended-Release Capsules, 15mg and 30mg is the generic version of UCB’s Ionamin Capsules, 15mg and 30mg. Phentermine Resin is indicated in the management of exogenous

The trial involved three patients who had experienced severe bleeds not controlled with by-passing agents were treated with OBI-1. The study confirmed that OBI-1 effectively resulted in hemostasis,

Mechlorethamine gel is indicated as a treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma (CTCL). The NDA submission is based in data

The initiative will help patients using acetaminophen to reduce the risk of accidental overdose. McNeil has informed the US Food and Drug Administration (FDA) that the new dosing